LON:PRM Proteome Sciences (PRM) Share Price, News & Analysis → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free PRM Stock Alerts GBX 3.50 -0.01 (-0.28%) (As of 04:44 PM ET) Add Compare Share Share Today's Range 3.19▼ 3.5050-Day Range 2.82▼ 4.5252-Week Range 2.65▼ 8.79Volume51,323 shsAverage Volume165,455 shsMarket Capitalization£10.33 millionP/E RatioN/ADividend Yield6.17%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Proteome Sciences alerts: Email Address Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read About Proteome Sciences Stock (LON:PRM)Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. It offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. The company also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers, as well as bioinformatics tools. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.Read More PRM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRM Stock News HeadlinesMay 2, 2024 | msn.comProtein profiling reveals impact of aging and resistance training on skeletal muscle proteomeApril 30, 2024 | americanbankingnews.comProteome Sciences (LON:PRM) Stock Passes Above 50-Day Moving Average of $3.63May 8, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.April 27, 2024 | finance.yahoo.comProteome Sciences Full Year 2023 Earnings: UK£0.008 loss per share (vs UK£0.004 profit in FY 2022)April 11, 2024 | msn.comConsumer microbiome startup Seed Health is rolling its profits into an AI science moonshotMarch 22, 2024 | msn.comResearchers analyze how the proteome of specific brain cells changes as we ageMarch 20, 2024 | uk.finance.yahoo.comProteome Sciences PLC (PRM.AQ)January 22, 2024 | finance.yahoo.comIf EPS Growth Is Important To You, Proteome Sciences (LON:PRM) Presents An OpportunityMay 8, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.January 4, 2024 | proactiveinvestors.com.auProteome Sciences opens lab in San DiegoJanuary 2, 2024 | proactiveinvestors.comProteome Sciences opens lab in San Diego’s biotech hubOctober 2, 2023 | lse.co.ukProteome Sciences sees shares surge on SysQuant service launchAugust 25, 2023 | uk.investing.comFTSE 100 Live: Stocks extend gains ahead of Jackson HoleAugust 25, 2023 | marketwatch.comProteome Sciences Shares Fall After Swing to Loss on Higher CostsAugust 15, 2023 | finance.yahoo.comWe Ran A Stock Scan For Earnings Growth And Proteome Sciences (LON:PRM) Passed With EaseMay 17, 2023 | marketwatch.comProteome Sciences Says It Is Well-Positioned for 2023 GrowthMay 12, 2023 | lse.co.ukProteome Sciences expanding to US with San Diego facilityApril 29, 2023 | fool.co.ukProteome SciencesMarch 8, 2023 | finance.yahoo.comDoes Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?January 25, 2023 | finanznachrichten.deAdvanced Proteome Therapeutics Corp.: Advanced Proteome Therapeutics Announces Its Proposed Plan of ArrangementAugust 30, 2022 | finance.yahoo.comHere's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of InvestorsAugust 5, 2022 | lse.co.ukProteome reaches milestone in launch of proteomics serviceMay 17, 2022 | lse.co.ukProteome Sciences maintains strong order bookDecember 14, 2021 | apnews.comBiognosys Expands Co-Marketing Agreement with Global Life Science Leader to Advance ProteomicsDecember 7, 2021 | finance.yahoo.comHere's Why I Think Proteome Sciences (LON:PRM) Might Deserve Your Attention TodayNovember 15, 2021 | finance.yahoo.comThermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument SolutionsSeptember 6, 2021 | finance.yahoo.comA Look At The Fair Value Of Proteome Sciences plc (LON:PRM)See More Headlines Receive PRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/10/2020Today5/08/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolLON:PRM CUSIPN/A CIKN/A Webwww.proteomics.com Phone+44-20-70432116FaxN/AEmployees29Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-2,440,000.00 Net Margins-48.59% Pretax MarginN/A Return on EquityN/A Return on Assets-8.48% Debt Debt-to-Equity RatioN/A Current Ratio0.33 Quick Ratio0.37 Sales & Book Value Annual Sales£5.03 million Price / Sales2.05 Cash FlowGBX 0.94 per share Price / Cash Flow3.73 Book ValueGBX (1) per share Price / Book-3.50Miscellaneous Outstanding Shares295,180,000Free FloatN/AMarket Cap£10.33 million OptionableNot Optionable Beta-0.02 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Mariola Sohngen (Age 63)CEO & Executive Director Comp: $310kMr. Abdelghani Omari (Age 48)CFO & Director Comp: $209kDr. Ian H. Pike (Age 60)Chief Scientific Officer & Executive Director Comp: $233kMr. Richard Paul Dennis (Age 66)Chief Commercial Officer & Executive Director Comp: $235kMr. Glenn BarneyVice President of Sales & MarketingVictoria Joanna BirseCompany SecretaryMore ExecutivesKey CompetitorsLungLife AILON:LLAIAbingdon HealthLON:ABDXGENinCodeLON:GENIgenedriveLON:GDRYourgene HealthLON:YGENView All Competitors PRM Stock Analysis - Frequently Asked Questions How have PRM shares performed in 2024? Proteome Sciences' stock was trading at GBX 4.53 on January 1st, 2024. Since then, PRM shares have decreased by 22.7% and is now trading at GBX 3.50. View the best growth stocks for 2024 here. How were Proteome Sciences' earnings last quarter? Proteome Sciences plc (LON:PRM) announced its quarterly earnings results on Monday, August, 10th. The company reported ($0.17) EPS for the quarter. What other stocks do shareholders of Proteome Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL), boohoo group (BOO), Mondi (MNDI), Petrofac (PFC), Lloyds Banking Group (LLOY), Falanx Group (FLX), Quanterix (QTRX), Centrica (CNA), CyanConnode (CYAN) and Eckoh (ECK). How do I buy shares of Proteome Sciences? Shares of PRM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:PRM) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
